DK0471036T4 - Indkapslingsfremgangsmåde - Google Patents

Indkapslingsfremgangsmåde

Info

Publication number
DK0471036T4
DK0471036T4 DK90908830T DK90908830T DK0471036T4 DK 0471036 T4 DK0471036 T4 DK 0471036T4 DK 90908830 T DK90908830 T DK 90908830T DK 90908830 T DK90908830 T DK 90908830T DK 0471036 T4 DK0471036 T4 DK 0471036T4
Authority
DK
Denmark
Prior art keywords
agent
effective amount
solvent
microdroplets
emulsion
Prior art date
Application number
DK90908830T
Other languages
Danish (da)
English (en)
Other versions
DK0471036T3 (da
Inventor
Thomas R Tice
Richard M Gilley
Original Assignee
Southern Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23363857&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0471036(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Southern Res Inst filed Critical Southern Res Inst
Application granted granted Critical
Publication of DK0471036T3 publication Critical patent/DK0471036T3/da
Publication of DK0471036T4 publication Critical patent/DK0471036T4/da

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/06—Making microcapsules or microballoons by phase separation
    • B01J13/12—Making microcapsules or microballoons by phase separation removing solvent from the wall-forming material solution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicinal Preparation (AREA)
  • Extrusion Moulding Of Plastics Or The Like (AREA)
  • Glass Compositions (AREA)
  • Injection Moulding Of Plastics Or The Like (AREA)
  • Electron Tubes For Measurement (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Surgical Instruments (AREA)
  • Press Drives And Press Lines (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Separation By Low-Temperature Treatments (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK90908830T 1989-05-04 1990-05-02 Indkapslingsfremgangsmåde DK0471036T4 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34747689A 1989-05-04 1989-05-04

Publications (2)

Publication Number Publication Date
DK0471036T3 DK0471036T3 (da) 1996-05-28
DK0471036T4 true DK0471036T4 (da) 2004-07-19

Family

ID=23363857

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90908830T DK0471036T4 (da) 1989-05-04 1990-05-02 Indkapslingsfremgangsmåde

Country Status (21)

Country Link
US (1) US5407609A (fr)
EP (1) EP0471036B2 (fr)
JP (1) JP2582186B2 (fr)
KR (1) KR0162660B1 (fr)
CN (1) CN1047223A (fr)
AT (1) ATE133087T1 (fr)
AU (1) AU5741590A (fr)
CA (1) CA2050911C (fr)
DE (1) DE69024953T3 (fr)
DK (1) DK0471036T4 (fr)
ES (1) ES2084698T5 (fr)
FI (1) FI103183B (fr)
GR (1) GR1000614B (fr)
HK (1) HK30897A (fr)
IE (1) IE69313B1 (fr)
IL (1) IL94296A (fr)
MX (1) MX20594A (fr)
NO (1) NO302683B1 (fr)
NZ (1) NZ233570A (fr)
WO (1) WO1990013361A1 (fr)
ZA (1) ZA903411B (fr)

Families Citing this family (338)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030161889A1 (en) * 1984-03-16 2003-08-28 Reid Robert H. Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
US5693343A (en) 1984-03-16 1997-12-02 The United States Of America As Represented By The Secretary Of The Army Microparticle carriers of maximal uptake capacity by both M cells and non-M cells
US6217911B1 (en) 1995-05-22 2001-04-17 The United States Of America As Represented By The Secretary Of The Army sustained release non-steroidal, anti-inflammatory and lidocaine PLGA microspheres
US6309669B1 (en) 1984-03-16 2001-10-30 The United States Of America As Represented By The Secretary Of The Army Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix
USRE40786E1 (en) 1984-03-16 2009-06-23 The United States Of America As Represented By The Secretary Of The Army Vaccines against intracellular pathogens using antigens encapsulated within biodegradable-biocompatible microspheres
US6410056B1 (en) 1984-03-16 2002-06-25 The United States Of America As Represented By The Secretary Of The Army Chemotherapeutic treatment of bacterial infections with an antibiotic encapsulated within a biodegradable polymeric matrix
US5985354A (en) * 1995-06-07 1999-11-16 Brown University Research Foundation Preparation of multiwall polymeric microcapsules from hydrophilic polymers
US5840293A (en) * 1988-11-16 1998-11-24 Advanced Polymer Systems, Inc. Ionic beads for controlled release and adsorption
AU8303691A (en) 1991-04-24 1992-12-21 United States Of America, As Represented By The Secretary Of The Army, The Oral-intestinal vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
CH683149A5 (fr) * 1991-07-22 1994-01-31 Debio Rech Pharma Sa Procédé pour la préparation de microsphères en matériau polymère biodégradable.
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
ZA93929B (en) * 1992-02-18 1993-09-10 Akzo Nv A process for the preparation of biologically active materialcontaining polymeric microcapsules.
US5922340A (en) 1992-09-10 1999-07-13 Children's Medical Center Corporation High load formulations and methods for providing prolonged local anesthesia
US6251920B1 (en) 1993-05-13 2001-06-26 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US5346738A (en) * 1992-11-04 1994-09-13 X-Cal Corporation Identification label with micro-encapsulated etchant
DE4244122C1 (de) * 1992-12-24 1994-06-01 Sanol Arznei Schwarz Gmbh Lyophilisierte, wirkstoffhaltige Emulsion zur intravenösen Applikation
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6663881B2 (en) 1993-01-28 2003-12-16 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6939546B2 (en) 1993-05-21 2005-09-06 The United States Of America As Represented By The Secretary Of The Army Model for testing immunogenicity of peptides
EP2283821A1 (fr) 1993-11-19 2011-02-16 Alkermes, Inc. Préparation des microparticules biodégradables contenant un agent biologiquement actif
US5650173A (en) * 1993-11-19 1997-07-22 Alkermes Controlled Therapeutics Inc. Ii Preparation of biodegradable microparticles containing a biologically active agent
ATE288270T1 (de) 1993-11-19 2005-02-15 Janssen Pharmaceutica Nv Mikroverkapselte 1,2-benzazole
IT1265290B1 (it) * 1993-12-17 1996-10-31 Dox Al Italia Spa Miscele ad elevato contenuto di sostanze attive idonee ad essere distribuite in modo omogeneo nei mangimi per animali.
US6447796B1 (en) 1994-05-16 2002-09-10 The United States Of America As Represented By The Secretary Of The Army Sustained release hydrophobic bioactive PLGA microspheres
US6855331B2 (en) 1994-05-16 2005-02-15 The United States Of America As Represented By The Secretary Of The Army Sustained release hydrophobic bioactive PLGA microspheres
US5622723A (en) * 1995-02-03 1997-04-22 Eurand America, Incorporated Procedure for encapsulating chlorpheniramine
US6902743B1 (en) 1995-05-22 2005-06-07 The United States Of America As Represented By The Secretary Of The Army Therapeutic treatment and prevention of infections with a bioactive material(s) encapuslated within a biodegradable-bio-compatable polymeric matrix
US7033608B1 (en) 1995-05-22 2006-04-25 The United States Of America As Represented By The Secretary Of The Army “Burst-free” sustained release poly-(lactide/glycolide) microspheres
US5883103A (en) * 1995-06-07 1999-03-16 Shire Laboratories Inc. Oral acyclovir delivery
US5879712A (en) * 1995-06-07 1999-03-09 Sri International Method for producing drug-loaded microparticles and an ICAM-1 dosage form so produced
HUP9700322A3 (en) 1995-06-09 2001-03-28 Euro Celtique Sa Formulations and methods for providing prolonged local anesthesia
US6248720B1 (en) 1996-07-03 2001-06-19 Brown University Research Foundation Method for gene therapy using nucleic acid loaded polymeric microparticles
US6143211A (en) * 1995-07-21 2000-11-07 Brown University Foundation Process for preparing microparticles through phase inversion phenomena
EP0840623B1 (fr) 1995-07-21 2007-07-18 Brown University Research Foundation Compositions pour la thérapie génétique contenant des microparticules polymères chargées d'un acide nucléique
US5766629A (en) 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
WO1997017063A1 (fr) † 1995-11-09 1997-05-15 Microbiological Research Authority Adn microencapsule s'appliquant dans des procedes de vaccination et de therapie genique
GB9709900D0 (en) 1997-05-15 1997-07-09 Microbiological Res Authority Microencapsulated DNA for vaccination and gene therapy
US6270795B1 (en) 1995-11-09 2001-08-07 Microbiological Research Authority Method of making microencapsulated DNA for vaccination and gene therapy
JPH09169610A (ja) * 1995-12-20 1997-06-30 Sumitomo Chem Co Ltd マイクロカプセル化された有害生物防除剤組成物
US5955143A (en) * 1995-12-21 1999-09-21 Drexel University Hollow polymer microcapsules and method of producing the same
US5792477A (en) * 1996-05-07 1998-08-11 Alkermes Controlled Therapeutics, Inc. Ii Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent
US6652837B1 (en) 1996-05-24 2003-11-25 Massachusetts Institute Of Technology Preparation of novel particles for inhalation
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
US20020052310A1 (en) * 1997-09-15 2002-05-02 Massachusetts Institute Of Technology The Penn State Research Foundation Particles for inhalation having sustained release properties
US5874064A (en) * 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
WO1997049391A1 (fr) 1996-06-24 1997-12-31 Euro-Celtique, S.A. Methodes sures d'anesthesie locale
US6046187A (en) 1996-09-16 2000-04-04 Children's Medical Center Corporation Formulations and methods for providing prolonged local anesthesia
US7060277B2 (en) * 1996-12-30 2006-06-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem Broad spectrum antagonists and vaccines directed against pyrogenic exotoxins
IL119938A (en) * 1996-12-30 2005-08-31 Yissum Res Dev Co Peptides capable of eliciting protective immunity against toxic shock induced by pyrogenic exotoxins or of antagonizing toxin-mediated activation of t cells
US20020182258A1 (en) * 1997-01-22 2002-12-05 Zycos Inc., A Delaware Corporation Microparticles for delivery of nucleic acid
US5783567A (en) * 1997-01-22 1998-07-21 Pangaea Pharmaceuticals, Inc. Microparticles for delivery of nucleic acid
US5945126A (en) * 1997-02-13 1999-08-31 Oakwood Laboratories L.L.C. Continuous microsphere process
ATE278397T1 (de) 1997-03-31 2004-10-15 Boston Scient Ltd Verwendung von cytoskelettinhibitoren zur vorbeugung der restenose
BR9815499A (pt) 1997-07-02 2001-01-02 Euro Celtique Sa Anestesia prolongada nas juntas e nos espacos corporais.
KR100380856B1 (ko) * 1997-07-19 2003-10-10 주식회사 엘지화학 카본블랙의고분자에의한피낭화방법
DK0942780T3 (da) * 1997-09-09 2003-10-27 Lyotropic Therapeutics Inc Overtrukne partikler, fremgangsmåder til fremstilling deraf og anvendelse deraf
US7052678B2 (en) 1997-09-15 2006-05-30 Massachusetts Institute Of Technology Particles for inhalation having sustained release properties
SE512663C2 (sv) * 1997-10-23 2000-04-17 Biogram Ab Inkapslingsförfarande för aktiv substans i en bionedbrytbar polymer
FR2771824A1 (fr) * 1997-12-01 1999-06-04 Eastman Kodak Co Utilisation de microvesicules contenant un developpateur des halogenures d'argent pour former une image photographique
US6197229B1 (en) * 1997-12-12 2001-03-06 Massachusetts Institute Of Technology Method for high supercoiled DNA content microspheres
US20020147143A1 (en) 1998-03-18 2002-10-10 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
KR100797876B1 (ko) 1998-04-07 2008-01-24 코릭사 코포레이션 마이코박테리움 튜베르쿨로시스 항원의 융합 단백질 및이의 용도
GB9810236D0 (en) 1998-05-13 1998-07-08 Microbiological Res Authority Improvements relating to encapsulation of bioactive agents
US6406719B1 (en) 1998-05-13 2002-06-18 Microbiological Research Authority Encapsulation of bioactive agents
EP1096957A1 (fr) 1998-06-18 2001-05-09 Johns Hopkins University School of Medicine Methodes et reactifs d'administration intramusculaire d'acides nucleiques
US6916490B1 (en) 1998-07-23 2005-07-12 UAB Research Center Controlled release of bioactive substances
US6264991B1 (en) 1998-08-18 2001-07-24 Southern Research Institute Compositions and methods for treating intracellular infections
JP4198318B2 (ja) 1998-08-19 2008-12-17 ヤーゴテック アクチェンゲゼルシャフト プロポフォールの注射可能水性分散物
US6956021B1 (en) 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
US20030235557A1 (en) 1998-09-30 2003-12-25 Corixa Corporation Compositions and methods for WT1 specific immunotherapy
US6270802B1 (en) 1998-10-28 2001-08-07 Oakwood Laboratories L.L.C. Method and apparatus for formulating microspheres and microcapsules
US20040009535A1 (en) 1998-11-27 2004-01-15 Celltech R&D, Inc. Compositions and methods for increasing bone mineralization
US6194006B1 (en) 1998-12-30 2001-02-27 Alkermes Controlled Therapeutics Inc. Ii Preparation of microparticles having a selected release profile
US6498153B1 (en) * 1998-12-31 2002-12-24 Akzo Nobel N.V. Extended release growth promoting two component composition
US6204308B1 (en) 1999-03-01 2001-03-20 Novartis Ag Organic compounds
US6306425B1 (en) 1999-04-09 2001-10-23 Southern Research Institute Injectable naltrexone microsphere compositions and their use in reducing consumption of heroin and alcohol
EP1044683A1 (fr) * 1999-04-15 2000-10-18 Debio Recherche Pharmaceutique S.A. Procédé de dispersion à une étape pour la microencapsulation de substances solubles dans l'eau
US6291013B1 (en) 1999-05-03 2001-09-18 Southern Biosystems, Inc. Emulsion-based processes for making microparticles
US6387986B1 (en) * 1999-06-24 2002-05-14 Ahmad Moradi-Araghi Compositions and processes for oil field applications
US6749835B1 (en) 1999-08-25 2004-06-15 Advanced Inhalation Research, Inc. Formulation for spray-drying large porous particles
US7678364B2 (en) 1999-08-25 2010-03-16 Alkermes, Inc. Particles for inhalation having sustained release properties
US20010036481A1 (en) * 1999-08-25 2001-11-01 Advanced Inhalation Research, Inc. Modulation of release from dry powder formulations
WO2001013891A2 (fr) * 1999-08-25 2001-03-01 Advanced Inhalation Research, Inc. Modulation de liberation a partir de formulations seches en poudre
KR100730440B1 (ko) 1999-08-27 2007-06-19 브룩우드 파마슈티컬스, 인코포레이티드 주사가능한 부프레노르핀 미세 입자 조성물 및 이의 용도
US6458387B1 (en) * 1999-10-18 2002-10-01 Epic Therapeutics, Inc. Sustained release microspheres
US6705757B2 (en) * 1999-11-12 2004-03-16 Alkermes Controlled Therapeutics, Inc. Ii Method and apparatus for preparing microparticles using in-line solvent extraction
US6331317B1 (en) 1999-11-12 2001-12-18 Alkermes Controlled Therapeutics Ii Inc. Apparatus and method for preparing microparticles
US6495166B1 (en) 1999-11-12 2002-12-17 Alkermes Controlled Therapeutics Inc. Apparatus and method for preparing microparticles using in-line solvent extraction
US7838037B2 (en) 1999-11-17 2010-11-23 Tagra Biotechnologies Ltd. Method of microencapsulation
US20050037086A1 (en) * 1999-11-19 2005-02-17 Zycos Inc., A Delaware Corporation Continuous-flow method for preparing microparticles
WO2001041927A1 (fr) * 1999-12-10 2001-06-14 Microban Products Company Resines d'echanges ioniques synthetiques antimicrobiennes
US7029700B2 (en) * 2000-01-14 2006-04-18 Brown University Research Foundation Micronized freeze-dried particles
CN1254541C (zh) 2000-02-23 2006-05-03 史密丝克莱恩比彻姆生物有限公司 新化合物
WO2001069245A2 (fr) * 2000-03-14 2001-09-20 Trustees Of Tufts College Detecteurs a activite croisee
AU2001257359A1 (en) 2000-04-27 2001-11-07 Verion Inc. Zero order release and temperature-controlled microcapsules and process for the preparation thereof
CN1189159C (zh) 2000-05-05 2005-02-16 欧莱雅 含水溶性美容活性组分水性核的微胶囊及含其的组合物
US6264987B1 (en) * 2000-05-19 2001-07-24 Alkermes Controlled Therapeutics Inc. Ii Method for preparing microparticles having a selected polymer molecular weight
US6495164B1 (en) 2000-05-25 2002-12-17 Alkermes Controlled Therapeutics, Inc. I Preparation of injectable suspensions having improved injectability
EP1292285A4 (fr) * 2000-06-02 2009-07-22 Eisai Corp North America Systemes de distribution d'agents bioactifs
EP1319069B1 (fr) 2000-06-28 2008-05-21 Corixa Corporation Compositions et methodes pour le traitement et le diagnostic du cancer du poumon
WO2002003961A1 (fr) * 2000-07-07 2002-01-17 Corixa Corporation Microspheres et adjuvants utilises pour l'administration de vaccins a base d'adn
MXPA03001997A (es) 2000-09-06 2004-10-15 Appleton Paper Inc Adhesivo microencapsulado in situ.
DE60131177T2 (de) 2000-09-06 2008-08-07 AP Pharma, Inc., Redwood Abbaubare polyacetal-polymere
US6824822B2 (en) * 2001-08-31 2004-11-30 Alkermes Controlled Therapeutics Inc. Ii Residual solvent extraction method and microparticles produced thereby
US6962716B1 (en) * 2000-09-27 2005-11-08 Board Of Regents, The University Of Texas System Compositions and methods for biodegradable microspheres as carriers of bioactive substances
JP2004509739A (ja) 2000-09-27 2004-04-02 ベリオン　インコーポレイテッド 即時水溶解性カプセルおよびその製法
US6471995B1 (en) 2000-09-27 2002-10-29 Alkermes Controlled Therapeutics, Inc. Ii Apparatus and method for preparing microparticles using liquid-liquid extraction
SE517421C2 (sv) 2000-10-06 2002-06-04 Bioglan Ab Mikropartiklar, lämpade för parenteral administration, väsentligen bestående av stärkelse med minst 85 % amylopektin och med reducerad molekylvikt, samt framställning därav
JP2004510730A (ja) 2000-10-06 2004-04-08 ヤゴテック　アーゲー 非経口的投与可能な制御放出微粒子調製物
SE517422C2 (sv) 2000-10-06 2002-06-04 Bioglan Ab Farmaceutiskt acceptabel stärkelse
WO2002043580A2 (fr) 2000-10-27 2002-06-06 Epic Therapeutics, Inc. Production de microspheres
AU2000202A (en) * 2000-10-31 2002-05-15 Pr Pharmaceuticals Inc Methods and compositions for enhanced delivery of bioactive molecules
SE518007C2 (sv) 2000-11-16 2002-08-13 Bioglan Ab Förfarande för framställning av mikropartiklar
SE518008C2 (sv) * 2000-11-16 2002-08-13 Bioglan Ab Parenteralt administrerbara mikropartiklar och förfarande för framställning av desamma
US20020114843A1 (en) 2000-12-27 2002-08-22 Ramstack J. Michael Preparation of microparticles having improved flowability
JP2005504715A (ja) * 2000-12-29 2005-02-17 アドバンスト インハレーション リサーチ，インコーポレイテッド 持続放出特性を有する吸入用粒子
US20020141946A1 (en) * 2000-12-29 2002-10-03 Advanced Inhalation Research, Inc. Particles for inhalation having rapid release properties
US20070142325A1 (en) * 2001-01-08 2007-06-21 Gustavsson Nils O Starch
WO2002062319A2 (fr) * 2001-01-19 2002-08-15 Corixa Corporation Administration sous forme de microspheres de peptides de mucine
WO2002058670A1 (fr) * 2001-01-25 2002-08-01 Euroceltique S.A. Anesthesie locale, et procede d'utilisation
US6613083B2 (en) 2001-05-02 2003-09-02 Eckhard Alt Stent device and method
CA2446788A1 (fr) 2001-05-09 2002-11-14 Corixa Corporation Compositions et procedes pour la therapie et le diagnostic du cancer de la prostate
US6590059B2 (en) 2001-05-11 2003-07-08 Ap Pharma, Inc. Bioerodible polyorthoesters from dioxolane-based diketene acetals
US20030152630A1 (en) * 2001-05-11 2003-08-14 Ng Steven Y. PEG-POE, PEG-POE-PEG, and POE-PEG-POE block copolymers
US6730772B2 (en) 2001-06-22 2004-05-04 Venkatram P. Shastri Degradable polymers from derivatized ring-opened epoxides
CA2452382A1 (fr) * 2001-07-10 2003-01-23 Corixa Corporation Compositions et procedes destines a l'administration de proteines et d'adjuvants encapsules dans des microspheres
JP2004537401A (ja) * 2001-08-08 2004-12-16 ブラウン ユニバーシティ リサーチ ファウンデーション 疎水性薬物の微粉砕方法
EP1418890B1 (fr) * 2001-08-16 2008-05-14 Baxter International Inc. Preparations de microparticules a base d'un agent propulseur
US20080026068A1 (en) * 2001-08-16 2008-01-31 Baxter Healthcare S.A. Pulmonary delivery of spherical insulin microparticles
US7105181B2 (en) * 2001-10-05 2006-09-12 Jagotec, Ag Microparticles
US6524606B1 (en) 2001-11-16 2003-02-25 Ap Pharma, Inc. Bioerodible polyorthoesters containing amine groups
JP4368198B2 (ja) * 2001-11-20 2009-11-18 アルカーメス，インコーポレイテッド 肺送達用の改良された粒状組成物
WO2003043603A1 (fr) * 2001-11-20 2003-05-30 Advanced Inhalation Research, Inc. Compositions particulaires destinees a augmenter la solubilite d'agents faiblement solubles
WO2003049701A2 (fr) * 2001-12-10 2003-06-19 Spherics, Inc. Procedes et produits utiles dans la formation et l'isolation de microparticules
EP1581119B1 (fr) 2001-12-17 2013-01-30 Corixa Corporation Compositions et procedes applicables a la therapie et au diagnostic pour la maladie intestinale inflammatoire
US7497623B2 (en) 2002-02-27 2009-03-03 Pactiv Corporation Packages with active agents
US20060286356A1 (en) * 2002-02-27 2006-12-21 Thomas Toby R Web materials with active agent
US20050220375A1 (en) * 2002-02-27 2005-10-06 Thomas Toby R Pakages with active agents
SE0201599D0 (sv) * 2002-03-21 2002-05-30 Skyepharma Ab Microparticles
US7157102B1 (en) 2002-05-31 2007-01-02 Biotek, Inc. Multi-layered microcapsules and method of preparing same
US7041320B1 (en) 2002-05-31 2006-05-09 Biotek, Inc. High drug loaded injectable microparticle compositions and methods of treating opioid drug dependence
US20040047835A1 (en) * 2002-09-06 2004-03-11 Cell Therapeutics, Inc. Combinatorial drug therapy using polymer drug conjugates
BR0314996A (pt) * 2002-10-02 2005-08-09 Zealand Pharma As Composição, composição farmaceuticamente aceitável, método para produzir a composição, métodos para estabilizar a exendina-4 (1-39) ou uma sua variante, derivado ou análogo contra a degradação, antes, durante ou após o uso pretendido, para tratar doenças, para tratar de estados de doenças associados com nìveis elevados de glicose do sangue, para a regulação dos nìveis de glicose do sangue, para a regulação do esvaziamento gástrico, para estimular a liberação de insulina em um mamìfero para reduzir o nìvel de glicose do sangue em um mamìfero, para reduzir o nìvel de lipìdeos plasmáticos em um mamìfero, para reduzir a mortalidade e a morbidez após o infarto miocárdico em um mamìfero, para estimular a liberação de insulina em um mamìfero, e para produzir uma exendina (1-39) estabilizada, e, exendina (1-39) estabilizada
US6800663B2 (en) * 2002-10-18 2004-10-05 Alkermes Controlled Therapeutics Inc. Ii, Crosslinked hydrogel copolymers
US20040097419A1 (en) * 2002-11-19 2004-05-20 Holger Petersen Organic compounds
US7691296B2 (en) * 2002-11-25 2010-04-06 Amorepacific Corporation Method for stabilizing active components using polyol/polymer microcapsule, and cosmetic composition containing the microcapsule
US20070207211A1 (en) * 2003-04-10 2007-09-06 Pr Pharmaceuticals, Inc. Emulsion-based microparticles and methods for the production thereof
PT1615959E (pt) 2003-04-10 2013-08-29 Evonik Corp Um método para a produção de micropartículas à base de emulsão
OA13160A (en) 2003-04-24 2006-12-13 Univ Vanderbilt Compositions and methods for controlling insects.
US7622269B2 (en) * 2004-03-19 2009-11-24 Tyratech, Inc. Methods of screening tyramine- and octopamine-expressing cells for compounds and compositions having potential insect control activity
US20060263403A1 (en) * 2003-04-24 2006-11-23 Essam Enan Compositions and methods for controlling insects involving the tyramine receptor
US20040224030A1 (en) * 2003-05-06 2004-11-11 Shastri Venkatram R. Microsphere delivery systems
US7578916B2 (en) * 2004-05-25 2009-08-25 Applied Biosystems, Llc Emulsions of ionic liquids
US7381409B2 (en) 2003-06-16 2008-06-03 Celltech R&D, Inc. Antibodies specific for sclerostin and methods of screening and use therefor
US7101617B2 (en) * 2003-07-10 2006-09-05 Motorola, Inc. Silicone dispensing with a conformal film
WO2005009356A2 (fr) * 2003-07-15 2005-02-03 Pr Pharmaceuticals, Inc. Procede de preparation de compositions a liberation controlee
JP2008518881A (ja) 2003-07-18 2008-06-05 オークウッド ラボラトリーズ，エル．エル．シー． 高分子組成物中の高分子の分子量低下、不純物形成およびゲル化の防止
US20050142205A1 (en) * 2003-07-18 2005-06-30 Julia Rashba-Step Methods for encapsulating small spherical particles prepared by controlled phase separation
US20070092452A1 (en) * 2003-07-18 2007-04-26 Julia Rashba-Step Methods for fabrication, uses, compositions of inhalable spherical particles
WO2005035088A2 (fr) * 2003-07-18 2005-04-21 Baxter International, Inc. Procedes de fabrication, utilisations et compositions de petites particules spheriques preparees par separation de phases controlee
JP2007508240A (ja) * 2003-07-22 2007-04-05 バクスター・インターナショナル・インコーポレイテッド 低分子量有機分子の小球状粒子ならびにその調製方法および使用方法
AU2004259209A1 (en) * 2003-07-23 2005-02-03 Pr Pharmaceuticals, Inc. Controlled release compositions
US20050245541A1 (en) * 2004-03-19 2005-11-03 Elliot Ehrich Methods for treating alcoholism
US20080226704A1 (en) * 2004-03-23 2008-09-18 Makoto Kigoshi Method of Producing Coated Fine Particles
PL2409707T3 (pl) 2004-04-15 2015-08-31 Amylin Pharmaceuticals Llc Urządzenie o przedłużonym uwalnianiu na bazie polimeru
US7919499B2 (en) 2004-04-22 2011-04-05 Alkermes, Inc. Naltrexone long acting formulations and methods of use
WO2005107714A2 (fr) * 2004-05-05 2005-11-17 Alkermes Controlled Therapeutics, Inc. Procede de formation de microparticules comportant un bisphosphonate et un polymere
EP1753404A1 (fr) 2004-05-12 2007-02-21 Baxter International Inc. Microsphères contenant des protéines et présentant un potentiel d"injectabilité à d"importants degrés de concentration de l"agent concerné
US8728525B2 (en) * 2004-05-12 2014-05-20 Baxter International Inc. Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
CA2566079A1 (fr) * 2004-05-12 2005-12-01 Terrence L. Scott Production et administration de microspheres d'acide nucleique
WO2005112885A2 (fr) * 2004-05-12 2005-12-01 Baxter International Inc. Administration de microspheres d'oligonucleotides antisens pour induire une tolerance de cellules dendritiques pour le traitement du diabete de type 1 insulino-dependant
US7740861B2 (en) * 2004-06-16 2010-06-22 University Of Massachusetts Drug delivery product and methods
EP2594259A1 (fr) 2004-08-04 2013-05-22 Brookwood Pharmaceuticals, Inc. Procédé de production de systèmes d'administration, et systèmes d'administration
KR101340946B1 (ko) * 2004-08-04 2013-12-13 알자 코포레이션 오름차 0차 방출 패턴을 나타내는 약물의 서방성 조성물,상기 조성물을 제조하는 방법
ES2375995T3 (es) * 2004-09-17 2012-03-08 University Of Massachusetts Composiciones y sus usos para deficiencias de enzima lisosomal.
US20060073208A1 (en) * 2004-10-01 2006-04-06 Allergan, Inc. Cosmetic neurotoxin compositions and methods
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
WO2006104623A2 (fr) 2005-03-25 2006-10-05 Appleton Papers Inc. Materiaux d'emballage et de stockage pouvant etre fixes par un adhesif
MX2007013356A (es) * 2005-04-27 2008-03-26 Baxter Int Microparticulas modificadas en la superficie y metodos de formacion y uso de las mismas.
WO2006127454A2 (fr) * 2005-05-23 2006-11-30 Appleton Papers Inc. Procede de fabrication de capsules de type huile dans l'eau et microcapsules produites selon ce procede
WO2007018736A2 (fr) * 2005-07-22 2007-02-15 Appleton Papers Inc. Adhesif structurel encapsule
US9693967B2 (en) * 2005-09-07 2017-07-04 Southwest Research Institute Biodegradable microparticle pharmaceutical formulations exhibiting improved released rates
WO2007038619A2 (fr) * 2005-09-27 2007-04-05 Amunix, Inc. Produits pharmaceutiques proteiques et utilisations de ceux-ci
US7855279B2 (en) * 2005-09-27 2010-12-21 Amunix Operating, Inc. Unstructured recombinant polymers and uses thereof
US20090099031A1 (en) * 2005-09-27 2009-04-16 Stemmer Willem P Genetic package and uses thereof
US7846445B2 (en) * 2005-09-27 2010-12-07 Amunix Operating, Inc. Methods for production of unstructured recombinant polymers and uses thereof
EP1948245B1 (fr) * 2005-10-24 2011-10-05 University of Massachusetts Compositions et utilisations de celles-ci dans le cadre d'une therapie genique pour traiter des pathologies osseuses
US20070138671A1 (en) * 2005-12-15 2007-06-21 Anastasiou Theodore J Encapsulated active material with reduced formaldehyde potential
JP5738516B2 (ja) 2005-12-30 2015-06-24 ゼンサン （シャンハイ） サイエンス アンド テクノロジー リミテッド 心機能改善のためのニューレグリンの徐放
CA2648718A1 (fr) 2006-04-07 2007-10-18 The Research Foundation Of State University Of New York Polypeptides du recepteur de la transcobalamine, acides nucleiques et modulateurs associes, procedes d'utilisation associes destines a moduler la croissance cellulaire et a traiter le cancer et la deficience en cobalamine
CN100385063C (zh) * 2006-04-25 2008-04-30 中原工学院 具有持久抗菌芳香效果的纺织品纳米后整理试剂及其制作工艺
US7959940B2 (en) 2006-05-30 2011-06-14 Advanced Cardiovascular Systems, Inc. Polymer-bioceramic composite implantable medical devices
US20070282434A1 (en) * 2006-05-30 2007-12-06 Yunbing Wang Copolymer-bioceramic composite implantable medical devices
US20070281031A1 (en) * 2006-06-01 2007-12-06 Guohan Yang Microparticles and methods for production thereof
US20080145462A1 (en) * 2006-06-27 2008-06-19 Essam Enan Compositions and methods for treating parasitic infections
US8685471B2 (en) * 2006-07-17 2014-04-01 Tyratech, Inc. Compositions and methods for controlling insects
EP2647712A3 (fr) * 2006-08-04 2013-11-20 Baxter International Inc Composition à base de microsphères destinée à la prévention et/ou inversion de nouveaux cas de diabète auto-immun
CA2670821C (fr) 2006-08-09 2012-05-15 Intarcia Therapeutics, Inc. Systemes d'administration osmotiques et ensembles pistons
WO2008060786A2 (fr) * 2006-10-06 2008-05-22 Baxter International Inc. Microcapsules contenant des microparticules modifiées en surface et leurs procédés de formation et d'utilisation
BRPI0806666A8 (pt) * 2007-01-16 2018-02-06 Tyratech Inc Composições e método para controle de praga
US20080233199A1 (en) * 2007-03-22 2008-09-25 Alkermes, Inc. Coacervation Process
CA2683610C (fr) 2007-04-23 2013-01-08 Intarcia Therapeutics, Inc. Formulations en suspension de peptides insulinotropes et leurs utilisations
JP2010530293A (ja) * 2007-05-21 2010-09-09 フイルメニツヒ ソシエテ アノニム 大きいコアセルベート化カプセル
US10092524B2 (en) 2008-06-11 2018-10-09 Edge Therapeutics, Inc. Compositions and their use to treat complications of aneurysmal subarachnoid hemorrhage
US8425591B1 (en) 2007-06-11 2013-04-23 Abbott Cardiovascular Systems Inc. Methods of forming polymer-bioceramic composite medical devices with bioceramic particles
US20080317865A1 (en) * 2007-06-20 2008-12-25 Alkermes, Inc. Quench liquids and washing systems for production of microparticles
MX2010001684A (es) * 2007-08-15 2010-04-21 Amunix Inc Composiciones y metodos para modificar propiedades de polipeptidos biologicamente activos.
EP2222283A2 (fr) * 2007-10-29 2010-09-01 University of Massachusetts Proteins de levure membranaire encapsulées de facon multilayer pour l'administration d'acides nucléiques (siadn)
US9090737B2 (en) * 2007-11-13 2015-07-28 Surmodics, Inc. Viscous terpolymers as drug delivery platform
US8619257B2 (en) 2007-12-13 2013-12-31 Kimberley-Clark Worldwide, Inc. Recombinant bacteriophage for detection of nosocomial infection
CA2709712C (fr) 2007-12-20 2016-05-10 Surmodics Pharmaceuticals, Inc. Procede pour preparer des microparticules ayant un faible volume de solvant residuel
EP3369427B1 (fr) * 2007-12-27 2021-10-13 TyraTech, Inc. Compositions antiparasitaires synergiques et procédés de criblage
US20100294989A1 (en) * 2007-12-28 2010-11-25 Shaffer Ii Edward O Small scale functional materials
US20100302487A1 (en) * 2007-12-28 2010-12-02 Storer Joey W Phase compensation film
WO2009102467A2 (fr) 2008-02-13 2009-08-20 Intarcia Therapeutics, Inc. Dispositifs, formulations et méthodes d’administration de plusieurs agents bénéfiques
WO2009111264A2 (fr) * 2008-02-29 2009-09-11 Alseres Pharmaceuticals, Inc. Administration systémique de purine pour moduler l’excroissance axonale des neurones du système nerveux central
US20090274906A1 (en) * 2008-05-01 2009-11-05 Appleton Papers Inc. Particle with low permeance wall
US8071214B2 (en) * 2008-05-01 2011-12-06 Appleton Papers Inc. Particle with selected permeance wall
US8067089B2 (en) * 2008-05-01 2011-11-29 Appleton Papers Inc. Cationic microcapsule particles
CA2723192A1 (fr) * 2008-05-07 2009-11-12 Surmodics, Inc. Administration de complexe d'acide nucleique a partir de particules
WO2010008582A2 (fr) 2008-07-18 2010-01-21 Rxi Pharmaceuticals Corporation Système permettant d'administrer un médicament aux cellules phagocytaires
US8367427B2 (en) * 2008-08-20 2013-02-05 Baxter International Inc. Methods of processing compositions containing microparticles
US20100047292A1 (en) * 2008-08-20 2010-02-25 Baxter International Inc. Methods of processing microparticles and compositions produced thereby
US8323615B2 (en) * 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing multi-phasic dispersions
US8323685B2 (en) * 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing compositions containing microparticles
ES2877206T3 (es) * 2008-09-18 2021-11-16 Evonik Corp Proceso de microencapsulación con disolvente y sal
EP2340309A2 (fr) 2008-09-22 2011-07-06 Rxi Pharmaceuticals Corporation Nanotransporteurs neutres
PT3228320T (pt) 2008-10-17 2020-03-26 Sanofi Aventis Deutschland Combinação de uma insulina e de um agonista do glp-1
US20110224312A1 (en) * 2008-11-17 2011-09-15 Wayne State University Engineering porous particles of water soluble therapeutics for pressurized metered-dose inhaler formulations
US20100168807A1 (en) * 2008-12-23 2010-07-01 Burton Kevin W Bioactive terpolymer compositions and methods of making and using same
US8951546B2 (en) * 2008-12-23 2015-02-10 Surmodics Pharmaceuticals, Inc. Flexible implantable composites and implants comprising same
US8974808B2 (en) 2008-12-23 2015-03-10 Surmodics, Inc. Elastic implantable composites and implants comprising same
US9480643B2 (en) 2008-12-23 2016-11-01 Surmodics Pharmaceuticals, Inc. Implantable composites and implants comprising same
EP2395982B1 (fr) 2008-12-23 2014-10-22 Surmodics Pharmaceuticals, Inc. Composites implantables comprenant un film de polymère adhésif biocompatible et un agent biologiquement actif libérables
US9415197B2 (en) * 2008-12-23 2016-08-16 Surmodics, Inc. Implantable suction cup composites and implants comprising same
US9493774B2 (en) 2009-01-05 2016-11-15 Rxi Pharmaceuticals Corporation Inhibition of PCSK9 through RNAi
US20100189763A1 (en) * 2009-01-23 2010-07-29 Heather Nettles Controlled release systems from polymer blends
EP2389413A1 (fr) * 2009-01-23 2011-11-30 Surmodics Pharmaceuticals, Inc. Mélanges de polymères comprenant des polymères ayant différentes unités non répétitives et leurs procédés de fabrication et d'utilisation
WO2010085607A1 (fr) * 2009-01-23 2010-07-29 Surmodics Pharmaceuticals, Inc. Procédé continu par émulsion double de fabrication de particules
US20100196436A1 (en) * 2009-01-30 2010-08-05 Gooberman Lance L Implants containing disulfiram and an anti-inflammatory agent
CN108530543B (zh) 2009-02-03 2023-06-23 阿穆尼克斯制药公司 延伸重组多肽和包含该延伸重组多肽的组合物
WO2010114770A1 (fr) * 2009-03-30 2010-10-07 Cerulean Pharma Inc. Conjugués polymère-agent, particules, compositions et procédés d'utilisation apparentés
US8455098B2 (en) * 2009-04-07 2013-06-04 Appleton Papers Inc. Encapsulated solid hydrophilic particles
US8791093B2 (en) * 2009-05-29 2014-07-29 Lance L. Gooberman Pharmaceutical delivery systems for treatment of substance abuse and other addictions
KR101853606B1 (ko) 2009-07-06 2018-05-03 사노피-아벤티스 도이칠란트 게엠베하 메티오닌을 함유하는 수성 인슐린 제제
CN102741275B (zh) 2009-08-24 2016-08-03 阿穆尼克斯运营公司 凝血因子ix组合物及其制备和使用方法
MX378797B (es) 2009-09-28 2025-03-10 Intarcia Therapeutics Inc Establecimiento y/o terminacion rapidos de suministro de estado estable sustancial de farmaco.
EP2482804A1 (fr) 2009-10-01 2012-08-08 Evonik Degussa Corporation Compositions à base de microparticules et méthodes de traitement de la dégénérescence maculaire liée à l'âge
BR112012009801A8 (pt) 2009-10-30 2016-08-30 Cns Therapeutics Inc Polipeptídeo neurturina e variante de neurturina
KR101337322B1 (ko) 2009-11-13 2013-12-06 사노피-아벤티스 도이칠란트 게엠베하 Ｇｌｐ-1 효능제 및 메티오닌을 포함하는 약제학적 조성물
DK2498802T3 (en) 2009-11-13 2015-04-13 Sanofi Aventis Deutschland Pharmaceutical composition comprising a GLP-1 agonist, insulin and a methionine
US8715544B2 (en) * 2009-12-21 2014-05-06 Appvion, Inc. Hydrophilic liquid encapsulates
US20110207653A1 (en) * 2009-12-21 2011-08-25 Adrian Raiche Microparticle Encapsulated Thiol-Containing Polypeptides Together with a Redox Reagent
BR112012015200B1 (pt) * 2009-12-22 2021-07-20 Evonik Corporation Processo para preparar micropartículas, e, conjunto de cabeça de trabalho para um misturador através de fluxo não estático
WO2011119995A2 (fr) 2010-03-26 2011-09-29 Cerulean Pharma Inc. Formulations et procédés d'utilisation
US9743688B2 (en) 2010-03-26 2017-08-29 Philip Morris Usa Inc. Emulsion/colloid mediated flavor encapsulation and delivery with tobacco-derived lipids
US20110269657A1 (en) 2010-04-28 2011-11-03 Jiten Odhavji Dihora Delivery particles
US9186642B2 (en) 2010-04-28 2015-11-17 The Procter & Gamble Company Delivery particle
US9993793B2 (en) 2010-04-28 2018-06-12 The Procter & Gamble Company Delivery particles
US20110319473A1 (en) 2010-06-29 2011-12-29 Surmodics, Inc. Compositions and methods for enhancement of nucleic acid delivery
WO2012024229A1 (fr) 2010-08-14 2012-02-23 University Of Massachusetts Particule de paroi cellulaire de levures pour administrer des nanoparticules ciblées sur le récepteur
AU2011291582A1 (en) * 2010-08-20 2013-03-07 Cerulean Pharma Inc. Conjugates, particles, compositions, and related methods
ES2606554T3 (es) 2010-08-30 2017-03-24 Sanofi-Aventis Deutschland Gmbh Uso de AVE0010 para la fabricación de un medicamento para el tratamiento de la diabetes mellitus de tipo 2
CA2809825A1 (fr) 2010-08-30 2012-03-08 Surmodics Pharmaceuticals, Inc. Terpolymeres biodegradables et melanges de terpolymeres comme adhesifs sensibles a la pression
CN103370057A (zh) 2010-09-30 2013-10-23 赢创有限公司 从微粒上除去残留有机溶剂的方法
WO2012044675A2 (fr) 2010-09-30 2012-04-05 Surmodics Pharmaceuticals, Inc. Méthode de préparation par émulsion de microparticules contenant une faible quantité de solvant résiduel
US8901092B2 (en) 2010-12-29 2014-12-02 Surmodics, Inc. Functionalized polysaccharides for active agent delivery
EP2672983B1 (fr) 2011-02-11 2017-04-19 Edge Therapeutics, Inc. Compositions et procédés d'amélioration de pronostic d'un être humain souffrant d'hémorragie sous arachnoïdienne
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
WO2012138854A1 (fr) 2011-04-05 2012-10-11 Edge Therapeutics Système d'administration de médicament intraventriculaire pour améliorer le résultat après une lésion cérébrale affectant le flux sanguin cérébral
EP2694031B1 (fr) 2011-04-07 2015-07-08 The Procter and Gamble Company Compositions d'après-shampooing à dépôt accru de microcapsules de polyacrylate
EP2694017B1 (fr) 2011-04-07 2019-05-22 The Procter and Gamble Company Compositions d'hygiène personnelle à dépôt accru de microcapsules de polyacrylate
JP5869663B2 (ja) 2011-04-07 2016-02-24 ザ プロクター アンド ギャンブルカンパニー ポリアクリレートマイクロカプセルの付着が増大したシャンプー組成物
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
WO2012164480A1 (fr) * 2011-05-30 2012-12-06 National Institute Of Immunology Composition de vaccin capable d'induire une réponse par anticorps mémoires à partir d'une seule application
CN103608030A (zh) 2011-06-21 2014-02-26 昂科发克特公司 用于治疗和诊断癌症的组合物和方法
PL2750699T3 (pl) 2011-08-29 2015-12-31 Sanofi Aventis Deutschland Kombinacja farmaceutyczna do stosowania w kontroli glikemii u pacjentów z cukrzycą typu 2
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
US10208086B2 (en) 2011-11-11 2019-02-19 Fred Hutchinson Cancer Research Center Cyclin A1-targeted T-cell immunotherapy for cancer
EP2822577B1 (fr) 2012-02-15 2019-02-06 Bioverativ Therapeutics Inc. Protéines de facteur viii de recombinaison
LT3564260T (lt) 2012-02-15 2023-01-10 Bioverativ Therapeutics Inc. Viii faktoriaus kompozicijos ir jų gamybos bei panaudojimo būdai
US20130260040A1 (en) * 2012-02-28 2013-10-03 Neil Werde Microencapsulated catnip oil and methods of using the same
US9408419B2 (en) 2012-03-23 2016-08-09 Victoria's Secret Store Brand Management, Inc. Moisturizing fabric material, use thereof in moisturizing bras, and method of manufacture
US9399019B2 (en) 2012-05-09 2016-07-26 Evonik Corporation Polymorph compositions, methods of making, and uses thereof
WO2014022859A1 (fr) 2012-08-03 2014-02-06 Essam Enan Compositions antiparasitaires et méthodes afférentes
CN104869981B (zh) 2012-11-09 2018-05-08 赢创有限公司 用于协调微粒性质的干燥方法
TWI641381B (zh) 2013-02-04 2018-11-21 法商賽諾菲公司 胰島素類似物及／或胰島素衍生物之穩定化醫藥調配物
TWI667255B (zh) 2013-08-14 2019-08-01 美商生物化學醫療公司 因子ｖｉｉｉ－ｘｔｅｎ融合物及其用途
CN112957455A (zh) 2014-01-09 2021-06-15 赛诺菲 胰岛素类似物和/或胰岛素衍生物的稳定化药物制剂
EP3091965A1 (fr) 2014-01-09 2016-11-16 Sanofi Formulations pharmaceutiques stabilisées sans glycérol d'analogues de l'insuline et/ou de dérivés de l'insuline
SG11201604706TA (en) 2014-01-09 2016-07-28 Sanofi Sa Stabilized pharmaceutical formulations of insulin aspart
SG11201605242YA (en) 2014-01-10 2016-07-28 Biogen Ma Inc Factor viii chimeric proteins and uses thereof
WO2015150942A2 (fr) 2014-03-29 2015-10-08 The WOCKHARDT LIMITED Procédé amélioré de préparation de microparticules
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
AU2015359376B2 (en) 2014-12-12 2021-09-09 Sanofi-Aventis Deutschland Gmbh Insulin glargine/lixisenatide fixed ratio formulation
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
CN113598842A (zh) 2015-06-03 2021-11-05 因塔西亚制药公司 植入物放置和移除系统
IL257231B (en) 2015-08-03 2022-09-01 Bioverativ Therapeutics Inc Factor ix fusion proteins and methods of making and using same
EP3390483B1 (fr) 2015-10-27 2022-05-18 The Procter & Gamble Company Encapsulation
BG112154A (bg) 2015-11-19 2017-05-31 СОФИЙСКИ УНИВЕРСИТЕТ "Св. Кл. Охридски" Метод за получаване на течни, по­ лутечни и твърди органични частици с контролирана форма и/или размер
MX2018010194A (es) 2016-02-23 2019-06-12 Biodelivery Sciences Int Inc Microsferas de buprenorfina de liberacion sostenida (srbm) y metodos de uso de las mismas.
KR102574993B1 (ko) 2016-05-16 2023-09-06 인타르시아 세라퓨틱스 인코포레이티드 글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법
WO2017199123A1 (fr) 2016-05-17 2017-11-23 Ecole Polytechnique Federale De Lausanne (Epfl) Dispositif et procédés d'élimination de phase d'enveloppe de capsules de type noyau-enveloppe
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
MX2019006444A (es) 2016-12-02 2019-10-30 Bioverativ Therapeutics Inc Métodos de tratamiento de artropatía hemofílica utilizando factores de coagulación quiméricos.
WO2018129058A1 (fr) 2017-01-03 2018-07-12 Intarcia Therapeutics, Inc. Méthodes comprenant l'administration continue d'un agoniste du récepteur glp-1 et la co-adminstration d'un médicament
US10894908B2 (en) 2017-01-27 2021-01-19 Encapsys, Llc Encapsulates
JP7167059B2 (ja) 2017-04-19 2022-11-08 フィオ ファーマシューティカルズ コーポレーション 核酸化合物の局所送達
GB201710973D0 (en) 2017-07-07 2017-08-23 Avacta Life Sciences Ltd Scaffold proteins
SI3793588T1 (sl) 2018-05-18 2025-07-31 Bioverativ Therapeutics Inc. Postopki zdravljenja hemofilije A
WO2019236669A1 (fr) * 2018-06-08 2019-12-12 The United States Of America, As Represented By The Secretary Of Agriculture Compositions contenant des composés organiques microencapsulés
DE112018007728T5 (de) 2018-06-14 2021-03-18 Centro De Investigación En Química Aplicada Methode zur Gewinnung poröser Partikel durch Trocknung / Abkühlung in einem hybriden Pulverisierungsverfahren
EP3908246B1 (fr) 2019-01-11 2024-11-20 Encapsys, LLC Incorporation de chitosane dans une paroi de microcapsule
US20200281195A1 (en) * 2019-03-04 2020-09-10 Xerox Corporation Essential oil microparticles for powder coating applications
JP7765379B2 (ja) 2019-08-12 2025-11-06 ピュリノミア バイオテック， インコーポレイテッド Ｃｄ３９発現細胞のａｄｃｃ標的化を介してｔ細胞媒介性免疫応答を促進及び増強するための方法及び組成物
TW202128775A (zh) 2019-10-16 2021-08-01 英商阿法克塔生命科學有限公司 PD-L1抑制劑-TGFβ抑制劑雙特異性藥物部分
MX2023004231A (es) 2020-10-16 2023-04-21 Procter & Gamble Composiciones de producto de consumo que comprenden una poblacion de encapsulados.
JP2023543578A (ja) 2020-10-16 2023-10-17 ザ プロクター アンド ギャンブル カンパニー 少なくとも２つの封入体集団を有する消費者製品組成物
US12486478B2 (en) 2020-10-16 2025-12-02 The Procter & Gamble Company Consumer products comprising delivery particles with high core:wall ratios
EP4247537A4 (fr) 2020-11-20 2024-10-23 Encapsys, LLC Microcapsules biodégradables à libération contrôlée
WO2022234003A1 (fr) 2021-05-07 2022-11-10 Avacta Life Sciences Limited Polypeptides se liant à cd33 avec protéine stefin a
TW202334196A (zh) 2021-10-07 2023-09-01 英商阿法克塔生命科學有限公司 Pd-l1結合多肽
EP4412711A1 (fr) 2021-10-07 2024-08-14 Avacta Life Sciences Limited Polypeptides sériques de liaison pd-l1 prolongés à demi-vie
WO2023153876A1 (fr) 2022-02-10 2023-08-17 주식회사 아피셀테라퓨틱스 Variants protéiques de stéfine a se liant de manière spécifique à cd40l et leurs utilisations
WO2023212483A1 (fr) 2022-04-29 2023-11-02 Purinomia Biotech, Inc. Méthodes et compositions pour le traitement de maladies et de troubles à éosinophiles
WO2023218243A1 (fr) 2022-05-12 2023-11-16 Avacta Life Sciences Limited Protéines de fusion de liaison lag-3/pd-l1
US20240147990A1 (en) 2022-10-21 2024-05-09 Encapsys, Llc Delivery Particles Based On Amine-Thiol-Ene Conjugates and Derivatives
CN119677834A (zh) 2022-12-01 2025-03-21 恩盖普有限公司 电荷改性壳聚糖交联包封物
EP4627031A1 (fr) 2022-12-01 2025-10-08 Encapsys, LLC Particules d'administration dégradables à partir de chitosane traité à l'acide mixte
CA3263674A1 (fr) 2022-12-01 2024-06-06 Encapsys, Llc Particules de distribution dégradables fabriquées à partir de chitosane modifié par initiateur redox
EP4735520A1 (fr) 2023-06-28 2026-05-06 Encapsys, LLC Compositions de particules d'administration de farine à base de plantes
WO2025128667A1 (fr) 2023-12-13 2025-06-19 Encapsys, Llc Particules d'administration dégradables à partir d'isocyanates mélangés comprenant une fraction aromatique et du chitosane
WO2025128660A1 (fr) 2023-12-13 2025-06-19 Encapsys, Llc Particules d'administration dégradables séchées à partir d'isocyanates mélangés comprenant une fraction aromatique et du chitosane
WO2025207733A1 (fr) 2024-03-28 2025-10-02 Encapsys, Llc Microcapsules biodégradables à libération contrôlée

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4572869A (en) * 1967-04-20 1986-02-25 Ppg Industries, Inc. Microcapsular opacifiers and method for their production
US3644963A (en) * 1969-07-24 1972-02-29 Federico Terranova Procedure for the removal of the bones from hams and similar cuts of meat
US3780195A (en) * 1969-10-22 1973-12-18 Balchem Corp Encapsulation process
US3664963A (en) * 1969-10-22 1972-05-23 Balchem Corp Encapsulation process
DE2059494B2 (de) * 1970-12-03 1972-03-16 Licentia Gmbh Biegsamer hohlleiter
US3790497A (en) * 1971-11-24 1974-02-05 Mitsubishi Rayon Co Method for producing water containing microcapsules
JPS528795B2 (fr) * 1971-12-30 1977-03-11
US4089800A (en) * 1975-04-04 1978-05-16 Ppg Industries, Inc. Method of preparing microcapsules
JPS528795A (en) * 1975-07-10 1977-01-22 Kyocera Corp Selective indication circuit
DE2930248A1 (de) * 1979-07-26 1981-02-12 Bayer Ag Verfahren zur herstellung von mikrokapseln
US4933105A (en) * 1980-06-13 1990-06-12 Sandoz Pharm. Corp. Process for preparation of microspheres
US4389330A (en) * 1980-10-06 1983-06-21 Stolle Research And Development Corporation Microencapsulation process
US4675189A (en) * 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
US4637905A (en) * 1982-03-04 1987-01-20 Batelle Development Corporation Process of preparing microcapsules of lactides or lactide copolymers with glycolides and/or ε-caprolactones
JPS6048923A (ja) * 1983-08-25 1985-03-16 Mitsui Toatsu Chem Inc 微小粒子の製造方法
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
US4818542A (en) * 1983-11-14 1989-04-04 The University Of Kentucky Research Foundation Porous microspheres for drug delivery and methods for making same
CA1287459C (fr) * 1986-10-01 1991-08-13 Mukesh Jain Methode de preparation de microspheres creuses
US5075109A (en) * 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
JPS63122620A (ja) * 1986-11-12 1988-05-26 Sanraku Inc ポリ乳酸マイクロスフエア及びその製造方法
FR2608942B1 (fr) * 1986-12-31 1991-01-11 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanocapsules
FR2608988B1 (fr) * 1986-12-31 1991-01-11 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanoparticules
US4897268A (en) * 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same

Also Published As

Publication number Publication date
IE69313B1 (en) 1996-09-04
KR0162660B1 (en) 1998-11-16
WO1990013361A1 (fr) 1990-11-15
EP0471036A4 (en) 1992-03-18
ZA903411B (en) 1991-02-27
FI103183B1 (fi) 1999-05-14
ES2084698T5 (es) 2005-03-01
JPH04505454A (ja) 1992-09-24
IL94296A (en) 1995-10-31
HK30897A (en) 1997-03-21
MX20594A (es) 1994-03-31
NO914292L (no) 1991-11-01
DE69024953T3 (de) 2005-01-27
US5407609A (en) 1995-04-18
ATE133087T1 (de) 1996-02-15
FI103183B (fi) 1999-05-14
EP0471036B1 (fr) 1996-01-17
NZ233570A (en) 1992-12-23
EP0471036B2 (fr) 2004-06-23
IL94296A0 (en) 1991-03-10
GR1000614B (el) 1992-08-31
NO302683B1 (no) 1998-04-14
GR900100330A (en) 1991-10-10
KR920700762A (ko) 1992-08-10
EP0471036A1 (fr) 1992-02-19
CA2050911A1 (fr) 1990-11-05
IE901616L (en) 1990-11-04
ES2084698T3 (es) 1996-05-16
JP2582186B2 (ja) 1997-02-19
DE69024953D1 (de) 1996-02-29
FI915129A0 (fi) 1991-10-30
CA2050911C (fr) 1997-07-15
AU5741590A (en) 1990-11-29
NO914292D0 (no) 1991-11-01
DK0471036T3 (da) 1996-05-28
CN1047223A (zh) 1990-11-28
DE69024953T2 (de) 1996-08-14

Similar Documents

Publication Publication Date Title
DK0471036T3 (da) Indkapslingsfremgangsmåde
ES8605983A1 (es) Un metodo de producir una microcapsula de liberacion prolongada de un farmaco soluble en agua
IE812327L (en) Microcapsules
ES524518A0 (es) Un procedimiento para preparar un agente anti-inflamatorio
EP0190833A3 (en) Method for producing microcapsule
UA26867C2 (uk) Спосіб отримаhhя рідких капсул ароматичhого масла та спосіб ароматизації харчових продуктів
HUT35284A (en) Preparatives consisting of bipolimers and process for their production
JPS5222669A (en) Enclosed type reserver used in master cylinder
JPS5215621A (en) Apparatus for producing pulp particles
ES446728A1 (es) Procedimiento para la produccion de hojas registradoras.
NL166258C (nl) Werkwijze voor de bereiding van verbindingen met werking tegen maagzweren, werkwijze voor de bereiding van preparaten die ze bevatten, en gevormde preparaten.
JPS529279A (en) Method of dividing a fluid containing a solid uniformly
JPS5456A (en) Organopolysiloxane emulsion
JPS51115915A (en) Method for preparing antimolds, antiseptics and substances preventing rancidity of higy purity
JPS51138055A (en) Separation method of oil and water
JPS51138735A (en) Preparation of aqueous p olyolefin suspension
JPS57150612A (en) Immediately releasing micro-capsule and its preparation
JPS52151085A (en) Metal die for measurement of shearing stress
JPS52138751A (en) Method and apparatus of crush clearance regulation
JPS523992A (en) Hydraulic servo cylinder device
JPS5368484A (en) Punching block
ES408424A1 (es) Un metodo para mantener la uniformidad de una mezcla de nu-trientes discretos mientras se microencapsulam.
JPS5278324A (en) Real time character recognition equipment of format discrimination typ e
JPS51147004A (en) Continuous charge and discharge system for fluid materials